SOURCE: Biodermis

November 07, 2013 10:00 ET

Patented Pro-Sil From Biodermis Takes Top Honors at MyFaceMyBody Awards in London

Pro-Sil Selected as Winner in "Best Home Use Device" Category

HENDERSON, NV--(Marketwired - Nov 7, 2013) - The MyFaceMyBody Awards are the only aesthetic and dentistry awards which give consumers a voice in their favorite brands, products and services. This year a team of international judges were also involved in drawing up the final shortlist in the 18 categories covering the dental, aesthetic and media industry. The MyFaceMyBody Awards, designed to recognize and reward brands for their product innovation, effectiveness and popularity, are attended by leading health and beauty professionals, beauty brands, journalists, TV personalities and celebrities. Because the Awards are determined by consumer votes, the process is more transparent, fair and meaningful to the winners.

"This is a prestigious honor, and a tribute to the commitment of Steve Donnelly and his team at Amred Healthcare. Last year, thanks to their efforts, Pro-Sil was included on the NHS Drug Tariff. Now, with the MyFaceMyBody Award recognition, we could not be happier with Pro-Sil's reception in the UK."
-- Jeff Schleuning, Ph.D. EVP, Partner, Biodermis

Introduced in 2006 as a convenient, easy-to-use, glide-on alternative to ointments, Pro-Sil® elevated silicone scar treatment products to a new level. The recently patented Pro-Sil stick was designed to store compactly and worry-free in a purse or pocket, without the drips or leaks associated with silicone ointments. In the U.K., Pro-Sil is distributed by Amred Healthcare ( Amred Healthcare can be reached online or by phone at 033-0333-0079.

"We are absolutely delighted to have won this award, and to be recognized in our first year of trading in the UK. Consumers know and believe in Pro-Sil, as it is their votes that led to this accolade. Working closely with our manufacturer, Biodermis, we can ensure quality scar treatments with the consumers needs being paramount."
-- Steve Donnelly, Managing Director, Amred Healthcare, LTD

For over 25 years, Biodermis has pioneered the development of innovative solutions for the skin, ranging from scar management medical devices, to liposuction compression foam therapy, to post operative care products and skin hydration systems.

Contact Information